Bang, C. H. . (2024) “Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors”, Acta Dermato-Venereologica, 104, p. adv34206. doi: 10.2340/actadv.v104.34206.